1-13 of 13
dabigatran etexilate
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

What we have learned about direct oral anticoagulant reversal

Deborah M. Siegal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 198–203.
https://doi.org/10.1182/hematology.2019000072
Published: 2019
Journal Articles

Reversal of direct oral anticoagulants: a practical approach

Andrew W. Shih, Mark A. Crowther
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 612–619.
https://doi.org/10.1182/asheducation-2016.1.612
Published: 2016
Journal Articles

Monitoring and reversal of direct oral anticoagulants

Adam Cuker, Deborah Siegal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 117–124.
https://doi.org/10.1182/asheducation.V2015.1.117.3916182
Published: 2015
Journal Articles

Monitoring target-specific oral anticoagulants

Barbara A. Konkle
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 329–333.
https://doi.org/10.1182/asheducation-2014.1.329
Published: 2014
Journal Articles

What is the role of hemodialysis for dabigatran-associated major bleeding?

Benjamin Kim, David A. Garcia
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 514–517.
https://doi.org/10.1182/asheducation-2014.1.514
Published: 2014
Journal Articles

Reversing targeted oral anticoagulants

Maureane Hoffman, Dougald M. Monroe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 518–523.
https://doi.org/10.1182/asheducation-2014.1.518
Published: 2014
Journal Articles

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Margaret V. Ragni
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 44–51.
https://doi.org/10.1182/asheducation-2013.1.44
Published: 2013
Journal Articles

Phase 4 research: what happens when the rubber meets the road?

Mark Crowther
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 15–18.
https://doi.org/10.1182/asheducation-2013.1.15
Published: 2013
Journal Articles

Pros and cons of new oral anticoagulants

Kenneth A. Bauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 464–470.
https://doi.org/10.1182/asheducation-2013.1.464
Published: 2013
Journal Articles

Thrombosis in pregnancy: updates in diagnosis and management

Ian A. Greer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 203–207.
https://doi.org/10.1182/asheducation.V2012.1.203.3798262
Published: 2012
Journal Articles

Perioperative management of patients on chronic antithrombotic therapy

Thomas L. Ortel
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 529–535.
https://doi.org/10.1182/asheducation.V2012.1.529.3799663
Published: 2012
Journal Articles

Warfarin Versus New Agents: Interpreting the Data

Jack Ansell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 221–228.
https://doi.org/10.1182/asheducation-2010.1.221
Published: 2010
Journal Articles

New Issues in Oral Anticoagulants

Charles W. Francis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 259–265.
https://doi.org/10.1182/asheducation-2008.1.259
Published: 2008